248 related articles for article (PubMed ID: 33208877)
21. UBR5 HECT domain mutations identified in mantle cell lymphoma control maturation of B cells.
Swenson SA; Gilbreath TJ; Vahle H; Hynes-Smith RW; Graham JH; Law HC; Amador C; Woods NT; Green MR; Buckley SM
Blood; 2020 Jul; 136(3):299-312. PubMed ID: 32325489
[TBL] [Abstract][Full Text] [Related]
22. c-IAP1 cooperates with Myc by acting as a ubiquitin ligase for Mad1.
Xu L; Zhu J; Hu X; Zhu H; Kim HT; LaBaer J; Goldberg A; Yuan J
Mol Cell; 2007 Dec; 28(5):914-22. PubMed ID: 18082613
[TBL] [Abstract][Full Text] [Related]
23. Stability of the HTLV-1 Antisense-Derived Protein, HBZ, Is Regulated by the E3 Ubiquitin-Protein Ligase, UBR5.
Panfil AR; Al-Saleem J; Howard CM; Shkriabai N; Kvaratskhelia M; Green PL
Front Microbiol; 2018; 9():80. PubMed ID: 29441057
[TBL] [Abstract][Full Text] [Related]
24. The CARM1-p300-c-Myc-Max (CPCM) transcriptional complex regulates the expression of
Lu W; Yang C; He H; Liu H
Int J Biol Sci; 2020; 16(6):1071-1085. PubMed ID: 32140074
[TBL] [Abstract][Full Text] [Related]
25. Targeting UBR5 inhibits postsurgical breast cancer lung metastases by inducing CDC73 and p53 mediated apoptosis.
Yu Z; Dong X; Song M; Xu A; He Q; Li H; Ouyang W; Chouchane L; Ma X
Int J Cancer; 2024 Feb; 154(4):723-737. PubMed ID: 37855385
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of cIAP1 as a strategy for targeting c-MYC-driven oncogenic activity.
Li H; Fang Y; Niu C; Cao H; Mi T; Zhu H; Yuan J; Zhu J
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9317-E9324. PubMed ID: 30181285
[TBL] [Abstract][Full Text] [Related]
27. Functional Roles of the E3 Ubiquitin Ligase UBR5 in Cancer.
Shearer RF; Iconomou M; Watts CK; Saunders DN
Mol Cancer Res; 2015 Dec; 13(12):1523-32. PubMed ID: 26464214
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus X protein enhances Myc stability by inhibiting SCF(Skp2) ubiquitin E3 ligase-mediated Myc ubiquitination and contributes to oncogenesis.
Lee S; Kim W; Ko C; Ryu WS
Oncogene; 2016 Apr; 35(14):1857-67. PubMed ID: 26165841
[TBL] [Abstract][Full Text] [Related]
29. ELL targets c-Myc for proteasomal degradation and suppresses tumour growth.
Chen Y; Zhou C; Ji W; Mei Z; Hu B; Zhang W; Zhang D; Wang J; Liu X; Ouyang G; Zhou J; Xiao W
Nat Commun; 2016 Mar; 7():11057. PubMed ID: 27009366
[TBL] [Abstract][Full Text] [Related]
30. The deubiquitinase USP38 promotes cell proliferation through stabilizing c-Myc.
Xu Z; Hu H; Fang D; Wang J; Zhao K
Int J Biochem Cell Biol; 2021 Aug; 137():106023. PubMed ID: 34102342
[TBL] [Abstract][Full Text] [Related]
31. Characterization of interaction and ubiquitination of phosphoenolpyruvate carboxykinase by E3 ligase UBR5.
Shen Q; Qiu Z; Wu W; Zheng J; Jia Z
Biol Open; 2018 Dec; 7(12):. PubMed ID: 30552140
[TBL] [Abstract][Full Text] [Related]
32. LncRNA-MIF, a c-Myc-activated long non-coding RNA, suppresses glycolysis by promoting Fbxw7-mediated c-Myc degradation.
Zhang P; Cao L; Fan P; Mei Y; Wu M
EMBO Rep; 2016 Aug; 17(8):1204-20. PubMed ID: 27317567
[TBL] [Abstract][Full Text] [Related]
33. MYC degradation under low O2 tension promotes survival by evading hypoxia-induced cell death.
Wong WJ; Qiu B; Nakazawa MS; Qing G; Simon MC
Mol Cell Biol; 2013 Sep; 33(17):3494-504. PubMed ID: 23816886
[TBL] [Abstract][Full Text] [Related]
34. The role of UBR5 in tumor proliferation and oncotherapy.
Hu B; Chen S
Gene; 2024 May; 906():148258. PubMed ID: 38331119
[TBL] [Abstract][Full Text] [Related]
35. The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation.
Adhikary S; Marinoni F; Hock A; Hulleman E; Popov N; Beier R; Bernard S; Quarto M; Capra M; Goettig S; Kogel U; Scheffner M; Helin K; Eilers M
Cell; 2005 Nov; 123(3):409-21. PubMed ID: 16269333
[TBL] [Abstract][Full Text] [Related]
36. R1 Regulates Prostate Tumor Growth and Progression By Transcriptional Suppression of the E3 Ligase HUWE1 to Stabilize c-Myc.
Lin TP; Li J; Li Q; Li X; Liu C; Zeng N; Huang JM; Chu GC; Lin CH; Zhau HE; Chung LWK; Wu BJ; Shih JC
Mol Cancer Res; 2018 Dec; 16(12):1940-1951. PubMed ID: 30042175
[TBL] [Abstract][Full Text] [Related]
37. A complex of the ubiquitin ligase TRIM32 and the deubiquitinase USP7 balances the level of c-Myc ubiquitination and thereby determines neural stem cell fate specification.
Nicklas S; Hillje AL; Okawa S; Rudolph IM; Collmann FM; van Wuellen T; Del Sol A; Schwamborn JC
Cell Death Differ; 2019 Mar; 26(4):728-740. PubMed ID: 29899379
[TBL] [Abstract][Full Text] [Related]
38. Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6.
Tan Y; Ci Y; Dai X; Wu F; Guo J; Liu D; North BJ; Huo J; Zhang J
Oncotarget; 2017 Jul; 8(29):47890-47901. PubMed ID: 28599312
[TBL] [Abstract][Full Text] [Related]
39. UBR E3 ligases and the PDIA3 protease control degradation of unfolded antibody heavy chain by ERAD.
Tang D; Sandoval W; Lam C; Haley B; Liu P; Xue D; Roy D; Patapoff T; Louie S; Snedecor B; Misaghi S
J Cell Biol; 2020 Jul; 219(7):. PubMed ID: 32558906
[TBL] [Abstract][Full Text] [Related]
40. Kaposi's Sarcoma-Associated Herpesvirus LANA Modulates the Stability of the E3 Ubiquitin Ligase RLIM.
Tadmor H; Greenway M; Ahuja A; Orgil O; Liao G; Ambinder RF; Hayward SD; Shamay M
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
